Cancer
Credibility 80
Patterns of Poly(ADP-Ribose) Polymerase Inhibitor Use and Overall Survival in United States Veterans With Prostate Cancer.
October 5, 2026 · Clinical genitourinary cancer
Key takeaway
This study found that for Black men with advanced prostate cancer, a specific treatment called PARP inhibitors works just as well as it does for White men, even though Black men often start this treatment later and have more aggressive disease. This matters because it shows this important treatment can benefit our community, and highlights that we need to ensure Black men get these treatments earlier.
Why this matters for our communities
Research in cancer helps close long-standing gaps in how Black and African American families are studied, diagnosed, and cared for. Use findings like this one to start informed conversations with your care team — not as a substitute for personal medical advice.
More in Cancer
February 1, 2027Dual-modal immunoassay for prostate cancer-derived exosomes enabled by a black phosphorus/silver SERS substrate and Yb/Er co-doped NaGdF4 UCL nanoprobes.Read December 18, 2026Factors Associated with Screening Mammography Utilization Among Women Veterans in VA Primary Care.Read November 16, 2026Characterizing prior symptomatic emergency department visits among patients undergoing unplanned colon cancer surgery.Read
